GEN - Genetic Engineering & Biotech NewsOriginal article
FMT Shows Promise for Peanut Allergy Tolerance in Phase I Trial
Phase 1positiveFMTPositive
AI Analysis
Summary
A Phase I trial demonstrated that fecal microbiota transplantation increased peanut tolerance in some adults with peanut allergy, with preclinical evidence suggesting bile acid metabolites may play a mechanistic role.
Clinical Trial Data
Phase
Phase I
Primary Endpoint
Met
Outcome Details
FMT increased peanut tolerance in some adults with peanut allergy; mouse studies suggested effect may depend on bile acid metabolites
Importance:5/10
Sentiment:
0.70
Phase IFMTpeanut allergyimmunologymicrobiometolerance
Read the original article
Published by GEN - Genetic Engineering & Biotech News on August 7, 2026 3:19 AM